The Bialystok Bariatric Surgery Study

Plain-language summary

This study examines the effects of bariatric (weight-loss) surgery in patients with severe obesity. It enrolls people with a body mass index of 40 kg/m² or higher, or 35 or higher with at least one obesity-related comorbidity. The study is a non-phase study and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Medical University of Bialystok

Intervention

Bariatric surgery

Start date

9/10/2015

Estimated completion

12/31/2026

Countries

Poland

Related genes

Locations

• Bialystok, Poland

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* BMI ≥ 40 kg/m2, or BMI ≥ 35 and at least one or more obesity-related co-morbidities such as type 2 diabetes (T2D), hypertension, sleep apnea and other respiratory disorders, non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities, gastrointestinal disorders, or heart disease.
* Inability to achieve a healthy weight loss sustained for a period of time with prior weight loss efforts
* Patient consent for participation in research project
* Willingness in participation in follow-up visits

Exclusion Criteria:

* substance abuse,
* uncontrolled psychiatric illness
* expected lack of compliance
* advanced-stage cancer

Non-obese control group:

* BMI \<30